Gastric Motility Disorder - Pipeline Review, H2 2012

Publisher Name :
Date: 31-Oct-2012
No. of pages: 40
Inquire Before Buying

Gastric Motility Disorder - Pipeline Review, H2 2012

Summary

Global Markets Direct's, 'Gastric Motility Disorder - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Gastric Motility Disorder, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Gastric Motility Disorder. Gastric Motility Disorder - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Gastric Motility Disorder.
- A review of the Gastric Motility Disorder products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Gastric Motility Disorder pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Gastric Motility Disorder.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Gastric Motility Disorder pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Gastric Motility Disorder - Pipeline Review, H2 2012

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Gastric Motility Disorder Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Gastric Motility Disorder 7
Gastric Motility Disorder Therapeutics under Development by Companies 9
Late Stage Products 10
Comparative Analysis 10
Mid Clinical Stage Products 11
Comparative Analysis 11
Early Clinical Stage Products 12
Comparative Analysis 12
Pre-Clinical Stage Products 13
Comparative Analysis 13
Gastric Motility Disorder Therapeutics - Products under Development by Companies 14
Companies Involved in Gastric Motility Disorder Therapeutics Development 15
Theravance, Inc. 15
Helsinn Healthcare S.A. 16
Tranzyme Pharma, Inc. 17
Concert Pharmaceuticals, Inc. 18
Elixir Pharmaceuticals, Inc. 19
Gastric Motility Disorder - Therapeutics Assessment 20
Assessment by Monotherapy Products 20
Assessment by Route of Administration 21
Assessment by Molecule Type 23
Drug Profiles 25
ulimorelin hydrochloride - Drug Profile 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
TZP-102 - Drug Profile 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
EX-1314 - Drug Profile 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
velusetrag - Drug Profile 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
ipamorelin - Drug Profile 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
TD-8954 - Drug Profile 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
Gastric Motility Disorder Therapeutics - Drug Profile Updates 34
Gastric Motility Disorder - Product Development Milestones 38
Featured News & Press Releases 38
Jun 06, 2012: Tranzyme To Present Data On TZP-102 At American Diabetes Association Scientific Sessions 38
Jun 01, 2012: RaQualia Pharma Initiates First-In-Human Study For 5-HT4 Partial Agonist RQ-00000010 38
Feb 29, 2012: RaQualia Pharma Receives MHRA Approval To Initiate First-In-Human Study For 5-HT4 Partial Agonist RQ-00000010 38
Appendix 39
Methodology 39
Coverage 39
Secondary Research 39
Primary Research 39
Expert Panel Validation 39
Contact Us 40
Disclaimer 40

List of Tables
Number of Products Under Development for Gastric Motility Disorder, H2 2012 7
Products under Development for Gastric Motility Disorder - Comparative Analysis, H2 2012 8
Number of Products under Development by Companies, H2 2012 9
Comparative Analysis by Late Stage Development, H2 2012 10
Comparative Analysis by Mid Clinical Stage Development, H2 2012 11
Comparative Analysis by Early Clinical Stage Development, H2 2012 12
Comparative Analysis by Pre-Clinical Stage Development, H2 2012 13
Products under Development by Companies, H2 2012 14
Theravance, Inc., H2 2012 15
Helsinn Healthcare S.A., H2 2012 16
Tranzyme Pharma, Inc., H2 2012 17
Concert Pharmaceuticals, Inc., H2 2012 18
Elixir Pharmaceuticals, Inc., H2 2012 19
Assessment by Monotherapy Products, H2 2012 20
Assessment by Stage and Route of Administration, H2 2012 22
Assessment by Stage and Molecule Type, H2 2012 24
Gastric Motility Disorder Therapeutics - Drug Profile Updates 34

List of Figures
Number of Products under Development for Gastric Motility Disorder, H2 2012 7
Products under Development for Gastric Motility Disorder - Comparative Analysis, H2 2012 8
Products under Development by Companies, H2 2012 9
Late Stage Products, H2 2012 10
Mid Clinical Stage Products, H2 2012 11
Early Clinical Stage Products, H2 2012 12
Pre-Clinical Stage Products, H2 2012 13
Assessment by Monotherapy Products, H2 2012 20
Assessment by Route of Administration, H2 2012 21
Assessment by Stage and Route of Administration, H2 2012 22
Assessment by Molecule Type, H2 2012 23
Assessment by Stage and Molecule Type, H2 2012 24

  • Gastritis - Pipeline Review, H2 2016
    Published: 30-Nov-2016        Price: US 2000 Onwards        Pages: 44
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastritis - Pipeline Review, H2 2016, provides an overview of the Gastritis (Gastrointestinal) pipeline landscape.Gastritis is characterized by inflammation or swelling of the lining of the stomach. Acute gastritis lasts for a short period of time while chronic gastritis lasts for a long period of time (months to years). Gastritis can be caused by medications such as ibuprofen, aspirin, naproxen on long period......
  • Peritonitis - Pipeline Review, H2 2016
    Published: 30-Nov-2016        Price: US 2000 Onwards        Pages: 48
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peritonitis - Pipeline Review, H2 2016, provides an overview of the Peritonitis (Gastrointestinal) pipeline landscape.Peritonitis is inflammation of the peritoneum. There are two types of peritonitis. Spontaneous bacterial peritonitis (SBP) is the result of an infection of the fluid in peritoneal cavity. Secondary peritonitis is usually due to an infection that has spread from digestive tract. Symptoms include......
  • Global Proglumide Market Research Report 2016
    Published: 29-Nov-2016        Price: US 2900 Onwards        Pages: 100
    Notes: Production, means the output of Proglumide Revenue, means the sales value of Proglumide This report studies Proglumide in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Tianyuan Pharmachemical Institute - Hubei Prosoerity Galaxy Chemical - Hubei Yikangyuan Chemical......
  • Global Anti-Peptic Ulcer Drugs Sales Market Report 2016
    Published: 29-Nov-2016        Price: US 4000 Onwards        Pages: 108
    Notes: Sales, means the sales volume of Anti-Peptic Ulcer Drugs Revenue, means the sales value of Anti-Peptic Ulcer Drugs This report studies sales (consumption) of Anti-Peptic Ulcer Drugs in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - AstraZeneca - Ask-pharm - Takeda - Yangtze Ri......
  • Europe Diarrhea Drug Market Report 2016
    Published: 25-Nov-2016        Price: US 3900 Onwards        Pages: 108
    Notes: Sales, means the sales volume of Diarrhea Drug Revenue, means the sales value of Diarrhea Drug This report studies sales (consumption) of Diarrhea Drug in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Ipsen - Evaluate - Potion-Pharm - Gamay - HPGC - ......
  • Global Drugs for Traveler's Diarrhea Market Research Report 2016
    Published: 25-Nov-2016        Price: US 2900 Onwards        Pages: 103
    Notes: Production, means the output of Drugs for Traveler's Diarrhea Revenue, means the sales value of Drugs for Traveler's Diarrhea This report studies Drugs for Traveler's Diarrhea in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - GSK - Salix Pharmaceuticals - Ch......
  • Europe Esomeprazole Market Report 2016
    Published: 25-Nov-2016        Price: US 3900 Onwards        Pages: 114
    Notes: Sales, means the sales volume of Esomeprazole Revenue, means the sales value of Esomeprazole This report studies sales (consumption) of Esomeprazole in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - AstraZeneca AB - Sandoz - Actavis - Teva - Mylan - K......
  • Irritable Bowel Syndrome - Pipeline Review, H2 2016
    Published: 16-Nov-2016        Price: US 2000 Onwards        Pages: 140
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Irritable Bowel Syndrome - Pipeline Review, H2 2016, provides an overview of the Irritable Bowel Syndrome (Gastrointestinal) pipeline landscape.Inflammatory Bowel Diseases (IBD) is a broad term that describes conditions with chronic or recurring immune response and inflammation of the gastrointestinal tract. Signs and symptoms include abdominal cramps and pain, diarrhea that may be bloody, weight loss, loss of......
  • Celiac Disease (CD) - Epidemiology Insights-2023- EU5
    Published: 01-Nov-2016        Price: US 1750 Onwards        Pages: 60
    DelveInsight's "Celiac Disease (CD) - Epidemiology Insights-2023- EU5" report provides an overview of the Celiac Disease and current scenario of the disease in the EU5 countries (France, Germany, Italy, Spain and UK)). It also includes historical and forecasted epidemiological data for the total prevalent and diagnosed prevalent cases of Celiac Disease in EU5 from 2013-2023. Celiac disease is a genetic autoimmune disease where the indigestion of gluten leads to damage in the small intesti......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs